These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26692100)

  • 21. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and function of microRNA-27b in hepatocellular carcinoma.
    He S; Zhang J; Lin J; Zhang C; Sun S
    Mol Med Rep; 2016 Mar; 13(3):2801-8. PubMed ID: 26846382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway.
    Cui C; Fu K; Yang L; Wu S; Cen Z; Meng X; Huang Q; Xie Z
    J Exp Clin Cancer Res; 2019 May; 38(1):229. PubMed ID: 31142329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXR2 contributes to cell proliferation and malignancy in human hepatocellular carcinoma.
    Wang X; He B; Gao Y; Li Y
    Tumour Biol; 2016 Aug; 37(8):10459-67. PubMed ID: 26846213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
    Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
    Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma.
    Zhang W; Sun H; Shi X; Wang H; Cui C; Xiao F; Wu C; Guo X; Wang L
    Tumour Biol; 2016 Jun; 37(6):7741-8. PubMed ID: 26695141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.
    Wang X; Han L; Zhang J; Xia Q
    Dig Dis Sci; 2015 Oct; 60(10):3011-8. PubMed ID: 26055238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway.
    Sui Y; Zheng X; Zhao D
    Tumour Biol; 2015 Nov; 36(11):8661-70. PubMed ID: 26044564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
    Yuan S; Lei S; Wu S
    Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma.
    Qin G; Luo M; Chen J; Dang Y; Chen G; Li L; Zeng J; Lu Y; Yang J
    Cancer Lett; 2016 Apr; 374(1):85-95. PubMed ID: 26872724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
    Zhang Q; Zhao S; Pang X; Chi B
    Oncol Rep; 2016 Mar; 35(3):1831-40. PubMed ID: 26677080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
    Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
    Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of Rab17 promotes tumourigenic properties of hepatocellular carcinoma cells via Erk pathway.
    Qi J; Zhao P; Li F; Guo Y; Cui H; Liu A; Mao H; Zhao Y; Zhang X
    Int J Clin Exp Pathol; 2015; 8(5):4963-71. PubMed ID: 26191189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DJ-1 knockdown inhibits growth and xenograft‑induced tumor generation of human hepatocellular carcinoma cells.
    Liu S; Long G; Wei H; Shi L; Yang Z; Liu D; Hu G; Qiu H
    Oncol Rep; 2015 Jan; 33(1):201-6. PubMed ID: 25384406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
    Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
    Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
    Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
    Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.
    Li X; Yang Z; Song W; Zhou L; Li Q; Tao K; Zhou J; Wang X; Zheng Z; You N; Dou K; Li H
    Int J Oncol; 2013 Sep; 43(3):793-802. PubMed ID: 23807724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.